Exercise and Parkinson’s disease: Linking in the cannabinoid type 1 (CB1) and type 2 (CB2) and mu-opioid receptors

Research output: Contribution to book/anthology/report/proceedingBook chapterResearchpeer-review

Abstract

Parkinson’s disease (PD) has motor alterations as typical symptoms; however, there are also a high prevalence of nonmotor symptoms such as pain, balance, depression with high impact on patient quality life. Pain is present in around of 85% of PD patients and is associated with abnormal processing in central areas of pain pathway, and opioid and endocannabinoid system can be involved. Physical exercise has beneficial effects on PD, improving motor and nonmotor symptoms. This chapter aimed to highlight studies that report the effectiveness of the intervention through exercise on nonmotor symptoms of patients and animal models of PD, focusing on opioid and endocannabinoid system. In general, the exercise and physical activity can improve many PD symptoms; it helps maintain balance, mobility, and the ability to perform daily routines. That physical activity can play a preventive and maintenance role of physical fitness and mental health for patients with PD and consequently improve quality of life of PD patients.

Original languageEnglish
Title of host publicationNeurobiology and Physiology of the Endocannabinoid System
Number of pages11
Place of publicationLondon
PublisherAcademic Press
Publication dateJan 2023
Pages137-147
ISBN (Print)9780323908788
ISBN (Electronic)9780323908771
DOIs
Publication statusPublished - Jan 2023

Keywords

  • Analgesia
  • Cannabinoid receptors
  • Endocannabinoid
  • Nonmotor symptoms
  • Opioid receptors
  • Pain
  • Parkinson’s disease
  • Physical activity
  • Treadmill exercise

Fingerprint

Dive into the research topics of 'Exercise and Parkinson’s disease: Linking in the cannabinoid type 1 (CB1) and type 2 (CB2) and mu-opioid receptors'. Together they form a unique fingerprint.

Cite this